With what the management has achieved over 5 years is remarkable.
From my experience with new medical inovation start ups that require regulatory approval to be used, it is a road less traveled.
When Brian Leadman started his vision of Resapp dx comparing it to a Star Trek Tricorder as used by his favorite character Bones the Enterprises Medical Officer...
I though about that today..so I looked at a YouTube interview of Brian Leadman.
I love the bit when he talks about where Prof Abeyratane first started research capturing cough sounds to diagnose respiratory illness funded by Gates Foundation and done....oh I love this.. In Indonesia ...great video
And now 4 years from this interview...Resapp dx had Indonesian Regulatory approval and is being used by one of the largest and well respected Telehealth platforms ALODOKTOR in Indonesia ...
I find this to be amazing.
At the time of this interview the shares were hovering around 30+ cents...
The massive potential is with Alodokter PING Medgate Doctor's on Demand in Australia Europe India and USA
As a Medical Clinician I knew this would be big...
I believe if Resapp dx gets 1000 uses out of 20,000 consults a day...
That's over $500,000 in revenue for next quarter...
And I see Medgate bringing $300,000
this quarter..
So my guestimate for 4th quarter revenue is $1.5 million
All my opinion
- Forums
- ASX - By Stock
- RAP
- Resapphealth 2022
Resapphealth 2022, page-63
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 152 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
SBW
SHEKEL BRAINWEIGH LTD
Dani Nadri, Country Manager Australia
Dani Nadri
Country Manager Australia
SPONSORED BY The Market Online